NICE says to restrict antibiotics in COPD

NICE says to restrict antibiotics in COPD

July 13 2018 Draft guidance is calling for health professionals to consider the risk of...

NICE updates guideline on rheumatoid arthritis

NICE updates guideline on rheumatoid arthritis

July 13 2018 NICE has issued a new version of its guideline on the management of rheumatoid...

Community pharmacy option for antihypertensives referral sees little increase in GP workload

Community pharmacy option for antihypertensives referral sees little increase in GP workload

July 11 2018 Community pharmacy referrals for hypertensive patients under the New Medicines...

CMO concludes cannabis products should move out of Schedule 1 classification

CMO concludes cannabis products should move out of Schedule 1 classification

July 9 2018 The Chief Medical Officer has recommended rescheduling cannabis-based products as...

GP partnership review invites views on how to reinvigorate the model

GP partnership review invites views on how to reinvigorate the model

July 6 2018 The Department of Health and Social Care has set out the lines of inquiry for the...

  • NICE says to restrict antibiotics in COPD

    NICE says to restrict antibiotics in COPD

    Friday, 13 July 2018 13:05
  • NICE updates guideline on rheumatoid arthritis

    NICE updates guideline on rheumatoid arthritis

    Friday, 13 July 2018 12:58
  • Community pharmacy option for antihypertensives referral sees little increase in GP workload

    Community pharmacy option for antihypertensives referral sees little increase in GP workload

    Wednesday, 11 July 2018 13:17
  • CMO concludes cannabis products should move out of Schedule 1 classification

    CMO concludes cannabis products should move out of Schedule 1 classification

    Monday, 09 July 2018 09:26
  • GP partnership review invites views on how to reinvigorate the model

    GP partnership review invites views on how to reinvigorate the model

    Friday, 06 July 2018 15:17

a alert imageJuly 6 2018

A medical device alert has been issued regarding a risk of false results when using Combur10 Test UX and Chemstrip 10 A test strips. Specifically, there is a potential risk of falsely low results when using the measuring test strips on the Urisys 1100 urine analyser.

Manufacturer Roche Diagnostics has identified incorrect Limits of Detection (LoD) for protein, nitrite, ketone bodies, leukocytes, and blood (intact erythrocytes), which may adversely impact patient treatment. 

A Field Safety Notice shows the updated LoD quantities for the test strips. Roche Diagnostics asks users to “be aware of the changed limits of detection in the method sheet of the test strip products for each individual test parameter.”

It has also provided a workaround which should be performed until further notice: “In case the Urisys 1100 is reporting negative results for protein, nitrite, ketone bodies, leukocytes or blood (intact erythrocytes), please verify the result by visual reading, using the colour scale provided on the test strip vial. In case of discrepant values, the visually determined value shall be reported.”

In the alert, the MHRA has said: “If any adverse event occurs relating to this issue please report this to MHRA via Yellow Card or the relevant devolved administrations (Scotland, Wales and Northern Ireland).”

Link:
MHRA alert       

Professional News

July 13 2018 Draft guidance is calling for health professionals to consider the risk of antimicrobial resistance when prescribing for chronic obstructive pulmonary disease (COPD).
July 11 2018 Community pharmacy referrals for hypertensive patients under the New Medicines Service has not increased GP workload appreciably. Analysis of 131,419 patient records in England has...